MA14.08 Longitudinal Symptoms and Health Utility Scores (HUS) in Patients Receiving PD-1 Inhibitors for Metastatic NSCLCC. Poletes,S.C. Cheng,L.J. Zhan,J. Lee,D. Patel,P.A. Bradbury,F.A. Shepherd,N.B. Leighl,A.G. Sacher,G. Liu,S.C. LauJournal of Thoracic Oncology(2022)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要